Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Zhonghua Yan Ke Za Zhi ; 59(1): 50-51, 2023 Jan 11.
Artículo en Chino | MEDLINE | ID: mdl-36631058

RESUMEN

Silicone oil insertion is a common modality in vitreoretinal surgeries after ocular perforating injury. It needs surgical removal after several months. Extraocular silicone oil migration to orbit and eyelid is uncommon complication. We reports a case of silicone oil migration to orbit and eyelid. A 41-year-old male presented with left upper eyelid swelling following silicone oil injection 3 years before admission. Orbital computed tomography scan showed multiple high-density well-defined masses in vitreous, left upper eyelid and orbit. We diagnosed the patient with orbital and eyelid mass, meanwhile, speculated mechanical ptosis. Excision of orbital and eyelid masses were performed. Cystic spaces with delicate fibrous wall and small vessels, and clear fluid in cyst were discovered on histologic examination. The patient was followed up after 1 week. The left upper eyelid slightly depressed and the mechanical ptosis was significantly improved.


Asunto(s)
Blefaroptosis , Lesiones Oculares , Masculino , Humanos , Adulto , Órbita , Aceites de Silicona/efectos adversos , Párpados , Lesiones Oculares/complicaciones
2.
Eur Rev Med Pharmacol Sci ; 24(6): 2784, 2020 03.
Artículo en Inglés | MEDLINE | ID: mdl-32271394

RESUMEN

The article "MiR-203 over-expression promotes prostate cancer cell apoptosis and reduces ADM resistance, by Chen LZ, Ding Z, Zhang Y, He ST, Wang XH, published in Eur Rev Med Pharmacol Sci. 2018 Jun;22(12):3734-3741. DOI: 10.26355/eurrev_201806_15253. PMID: 29949147" has been withdrawn from the authors. The Publisher apologizes for any inconvenience this may cause.

3.
Eur Rev Med Pharmacol Sci ; 22(12): 3734-3741, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29949147

RESUMEN

OBJECTIVE: Extra-cellular signal regulated kinase (ERK)/mitogen activated protein kinase (MAPK) signaling pathway is widely involved in cell proliferation, apoptosis, and drug resistance. MAPK kinase 1 (MEK1) is the upstream protein kinase of ERK that can activate ERK/MAPK signaling pathway. microRNA 203 (MiR-203) down-regulation is found to be associated with prostate cancer pathogenesis. Bioinformatics analysis showed the complementary targeted relationship between miR-203 and the 3'-UTR of MEK1 mRNA. This study explored the role of miR-203 in regulating prostate cancer cell proliferation, apoptosis, and ADM resistance through affecting MEK1 expression. MATERIALS AND METHODS: Dual luciferase assay confirmed the targeted relationship between miR-203 and MEK1. MiR-203, MEK1, p-ERK1/2, and B cell lymphoma 2 (Bcl-2) expressions were compared in normal prostate epithelial cells PrEC, prostate cancer cells PC-3M, and drug resistance cells PC-3M/ADM. PC-3M, PC-3M/ADM cell apoptosis and proliferation were detected by using flow cytometry under ADM treatment at IC50 concentration of PC-3M cells. PC-3M cells were cultured in vitro and divided into four groups, including microRNA-normal control (miR-NC), miR-203 mimic, small interfere NC (si-NC), and si-MEK1. RESULTS: MiR-203 targeted and inhibited MEK1 expression. MiR-203 levels and cell apoptosis were significantly lower, while MEK1, p-ERK1/2, Bcl-2, and cell proliferation were significantly higher in PC-3M/ADM cells compared to the PC-3M cells. MiR-203 mimic and/or si-MEK1 transfection significantly reduced MEK1, p-ERK1/2, and Bcl-2 levels, attenuated cell proliferation, induced cell apoptosis, and decreased drug resistance. CONCLUSIONS: MiR-203 elevation suppressed prostate cancer PC-3M cell proliferation, promoted apoptosis, and weakened ADM resistance through targeted inhibiting MEK1 expression to alleviate ERK/MAPK signaling pathway and Bcl-2 expression.


Asunto(s)
Adrenomedulina/biosíntesis , Apoptosis/fisiología , Resistencia a Antineoplásicos/fisiología , MicroARNs/biosíntesis , Neoplasias de la Próstata/metabolismo , Adrenomedulina/genética , Línea Celular Tumoral , Regulación Neoplásica de la Expresión Génica , Humanos , Sistema de Señalización de MAP Quinasas/fisiología , Masculino , MicroARNs/genética , Neoplasias de la Próstata/genética
4.
Exp Clin Endocrinol Diabetes ; 121(9): 556-60, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-24127308

RESUMEN

OBJECTIVE: To investigate BANK1 gene variation, and its association with autoimmune thyroid disease and clinical features. METHOD: We genotyped 3 single nucleotide polymorphisms (SNPs) rs10516487, rs3733197 and rs4522865 of BANK1 gene in 667 patients with autoimmune thyroid diseases (417 with Graves' disease and 250 with Hashimoto's thyroiditis) and 301 healthy controls. The Matrix Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometer (MALDI-TOF-MS) Platform was used to detect the 3 SNPs. RESULTS: There was a significant association in rs3733197 A allele and AITD patients (P=0.043). SNP rs3733197 A allele was found in 29.63% chromosome of AITD patients who are 18 years old or below, compared with 19.90% chromosome in those 19 years or above (P=0.017). Also SNP rs3733197 A allele showed a significant association in HT patients when compared with controls (P=0.031, OR=0.73 and 95% CI=0.55-0.97). Stratification for specific autoantibodies in AITD patients TGAb positive when compared with SE (shared epitope) positive showed a significant association in rs3733197 SNP (P=0.010, OR=0.68 and 95%=CI 0.51-0.91). However, no significant association was found between 3 SNPs and GD. CONCLUSION: Our findings suggest the existence of association between BANK1 gene and AITD thus adding BANK1 gene to the list of the predisposing genes to AITD.


Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/genética , Proteínas de la Membrana/genética , Tiroiditis Autoinmune/genética , Adolescente , Adulto , Edad de Inicio , Anciano , Alelos , Estudios de Casos y Controles , Niño , Preescolar , ADN/genética , Femenino , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Variación Genética , Genotipo , Enfermedad de Graves/genética , Oftalmopatía de Graves/genética , Oftalmopatía de Graves/patología , Enfermedad de Hashimoto/genética , Humanos , Lactante , Yoduro Peroxidasa/genética , Masculino , Persona de Mediana Edad , Fenotipo , Polimorfismo de Nucleótido Simple , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción , Tiroglobulina/inmunología , Adulto Joven
5.
Hunan Yi Ke Da Xue Xue Bao ; 26(1): 26-30, 2001 Feb 28.
Artículo en Chino | MEDLINE | ID: mdl-12536608

RESUMEN

OBJECTIVE: To investigate the effects of Nao-yi-an (NYA) on protecting the cultured hippocampal neurons against the injury induced by hemoglobin (Hb) and modulating the expressions of nerve growth factor (NGF) and interleukin-1 beta (IL-1 beta) following Hb injury. METHODS: The experimental techniques of neuronal culture, alive cells count, Northern blotting, and enzymelinked immunosorbent assay (ELISA) were employed to detect the survival rate of cultured neurons, the expression level of NGF and IL-1 beta following Hb injury in cultured hippocampal neurons. RESULTS: 1. The hippocampal neurons survived for more than 5 months in Dulbecco's modified Eagle medium (DMEM) containing 2% bovine serum. 2. 38.5% cultured neurons were dead in Lock' s solution with 5 mmol.L-1 glucose containing 50 mumol.L-1 Hb. The rate of survival neurons was significantly increased by addition of decoction of NYA. 3. The expression of IL-1 beta was markedly increased at 1 h, 3 h, 6 h, and 12 h after Hb injury. The expression of NGF was temporarily increased. 4. The levels of IL-1 beta mRNA and protein were significantly decreased in NYA treated group, while the expression of NGF mRNA and protein was not reduced. CONCLUSION: NYA has the effects on increasing the neuronal survival, decreasing the expression of IL-1 beta, and maintaining the expression of NGF following Hb injury in cultured neurons.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Hipocampo/patología , Interleucina-1/biosíntesis , Factor de Crecimiento Nervioso/biosíntesis , Fármacos Neuroprotectores/farmacología , Animales , Células Cultivadas , Femenino , Feto , Hemoglobinas , Masculino , Neuronas/patología , Ratas , Ratas Sprague-Dawley
6.
World J Gastroenterol ; 7(5): 735-40, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11819866

RESUMEN

AIM: To observe the effects of Qiwei Baizhu Powder (QWBZP) on rotaviral gastroenteritis in children and in animal models. METHODS: Enrolled patients were divided into two groups, and one group was treated with oral rehydration solution (ORS) and the other treated with oral liquid of QWBZP. Neonate mice were orally infected with 50 microL rotavirus suspension (4 X 10(8) PFU/mL) and treated with ORS or oral liquid of QWBZP, respectively. RESULTS: Eighty-three cases of rotaviral gastroenteritis treated with QWBZP revealed a better efficacy than that treated with ORS (X(2)=10.87, P < 0.05). The contents of sodium and glucose as well as number of patients with positive human rotavirus antigen in stool in QWBZP group were all less than that in ORS group. In animal models, QWBZP was found effective in treating rotavirus gastroenteritis in neonate NIH mice, as compared with control groups. In QWBZP group, the mortality of infected mice was decreased by 73.3%, the body weight of infected mice was increased, the contents of sodium and glucose as well as number of mice with positive rotavirus antigen in feces were significantly reduced, and the pathological changes such as damage of small intestinal mucosa and villi were also obviously alleviated. CONCLUSION: QWBZP has effects on improving the absorptive function of small intestine, shortening the duration of diarrhea and rotavirus shedding from stool and alleviating the pathological changes of small intestine induced by rotavirus.


Asunto(s)
Medicamentos Herbarios Chinos/uso terapéutico , Gastroenteritis/tratamiento farmacológico , Gastroenteritis/virología , Infecciones por Rotavirus/tratamiento farmacológico , Administración Oral , Animales , Peso Corporal , Preescolar , Diarrea/tratamiento farmacológico , Diarrea/mortalidad , Diarrea/patología , Modelos Animales de Enfermedad , Electrólitos/sangre , Heces , Femenino , Fluidoterapia , Gastroenteritis/mortalidad , Glucosa/metabolismo , Humanos , Lactante , Intestinos/patología , Masculino , Ratones , Embarazo , Infecciones por Rotavirus/mortalidad , Infecciones por Rotavirus/patología , Sodio/metabolismo
7.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 16(3): 132-5, 1996 Mar.
Artículo en Chino | MEDLINE | ID: mdl-9208531

RESUMEN

Sixty cases of rotaviral enteritis treated with Qiwei Baizhu Powder (QWBZP) revealed a better efficacy than that treated with Oral Rehydration solution (ORS, chi 2 = 6.07, P < 0.05). The content of Na+ and glucose as well as number of patients with positive human rotavirus (HRV) antigen in faeces in QWBZP group were less than that in ORS group (chi 2 = 18.09, P < 0.05). In experimental study, QWBZP was found to be effective in treating HRV enteritis of newborn NIH mice in vivo, as compared with the control groups, the mortality of mice was decreased by 73.3%, the content of Na+ and glucose as well as number of mice with positive HRV antigen in faeces was markedly reduced, the pathological changes of intestine such as the damage of small intestinal mucosa and the exfoliation of intestinal villi were also obviously alleviated.


Asunto(s)
Antígenos Virales/metabolismo , Medicamentos Herbarios Chinos/uso terapéutico , Enteritis/tratamiento farmacológico , Infecciones por Rotavirus/tratamiento farmacológico , Rotavirus/inmunología , Animales , Enteritis/terapia , Enteritis/virología , Femenino , Fluidoterapia , Humanos , Lactante , Mucosa Intestinal/patología , Masculino , Ratones , Infecciones por Rotavirus/terapia
8.
Zhongguo Zhong Xi Yi Jie He Za Zhi ; 15(11): 669-71, 1995 Nov.
Artículo en Chino | MEDLINE | ID: mdl-8732153

RESUMEN

Qiwei Baizhu San was found to have an inhibitory effect on human rotavirus (HRV)at monolayer of MA104 Cells. A 50% reduction in plaque number, a 10(1.86)TCID50 decrease in viral replication index and around 60% inhibition in viral RNA synthesis were observed at concentration of 100 mg/ml. Furthermore, the cytotoxicity of the decoction was low, while its promoting effect on growth and proliferation of the culture cells was observed at the concentrations of 12.5-50 mg/ml. The decoction was also found to have effects in prolonging the survival time of HRV infected cells and promoting the regeneration of the infected cells.


Asunto(s)
Antivirales/farmacología , Medicamentos Herbarios Chinos/farmacología , Rotavirus/fisiología , Replicación Viral/efectos de los fármacos , Animales , Células Cultivadas , Riñón/citología , Macaca mulatta , ARN Viral/biosíntesis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA